Francesca Rogai

Mongersen, an Oral <i>SMAD7</i> Antisense Oligonucleotide, and Crohn’s Disease

Giovanni Monteleone, Markus F. Neurath, Sandro Ardizzone et al. · New England Journal of Medicine · 2015 · 396 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

A Predictive Model Identifies Patients Most Likely to Have Inadequate Bowel Preparation for Colonoscopy

Cesare Hassan, Lorenzo Fuccio, M. Bruno et al. · Clinical Gastroenterology and Hepatology · 2012 · 278 citations · Full text

Medicine, Clinical Sciences, Gastroenterology +11

Predictive Factors of Mortality From Nonvariceal Upper Gastrointestinal Hemorrhage: A Multicenter Study

Riccardo Marmo, M. Koch, Livio Cipolletta et al. · The American Journal of Gastroenterology · 2008 · 173 citations

Medicine, Clinical Sciences, Surgery +16

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15